Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	1,158	1,076	1,014	1,061	-	-	Upgrade
Market Cap Growth	19.61%	6.13%	-4.48%	-	-	-	Upgrade
Enterprise Value	2,953	2,208	1,993	1,760	-	-	Upgrade
Last Close Price	11.00	10.40	9.21	9.92	-	-	Upgrade
Price/FFO Ratio	6.35	6.15	5.80	6.28	-	-	Upgrade
Price/AFFO Ratio	-	8.99	8.15	8.09	-	-	Upgrade
PE Ratio	21.68	19.48	13.09	-	-	-	Upgrade
PS Ratio	2.80	3.08	3.26	3.78	-	-	Upgrade
PB Ratio	0.68	0.72	0.64	0.69	-	-	Upgrade
P/OCF Ratio	8.26	9.20	8.03	9.19	-	-	Upgrade
EV/Sales Ratio	7.20	6.33	6.41	6.27	-	-	Upgrade
EV/EBITDA Ratio	14.23	12.58	12.94	12.89	-	-	Upgrade
EV/EBIT Ratio	14.34	12.66	13.03	12.97	-	-	Upgrade
Debt / Equity Ratio	1.06	0.91	0.80	0.49	0.43	0.61	Upgrade
Debt / EBITDA Ratio	8.67	7.76	8.23	5.49	7.26	-	Upgrade
Asset Turnover	0.13	0.12	0.12	0.12	0.09	0.11	Upgrade
Quick Ratio	0.04	0.06	0.19	0.29	0.04	0.03	Upgrade
Current Ratio	0.96	0.65	0.71	0.98	0.05	0.04	Upgrade
Return on Equity (ROE)	3.26%	3.73%	4.88%	-0.56%	21.36%	-44.57%	Upgrade
Return on Assets (ROA)	3.97%	3.84%	3.55%	3.56%	2.97%	3.04%	Upgrade
Return on Capital (ROIC)	4.09%	3.97%	3.67%	3.69%	3.38%	3.71%	Upgrade
Earnings Yield	4.61%	5.13%	7.64%	-0.84%	-	-	Upgrade
Dividend Yield	5.56%	5.63%	6.76%	5.97%	-	-	Upgrade
Payout Ratio	115.79%	102.29%	77.50%	-	0.08%	-	Upgrade
Buyback Yield / Dilution	-11.42%	-8.61%	0.33%	1.52%	-	-	Upgrade
Total Shareholder Return	-5.86%	-2.98%	7.09%	7.49%	-	-	Upgrade

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.